• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年高血压患者是否应接受治疗?来自临床试验的证据。

Should the elderly hypertensive be treated? Evidence from clinical trials.

作者信息

Davidson R A, Caranasos G J

机构信息

Department of Medicine, University of Florida, Gainesville 32610.

出版信息

Arch Intern Med. 1987 Nov;147(11):1933-7.

PMID:3314763
Abstract

Clinical trials for over 15 years have addressed the therapeutic utility of treating elderly hypertensives. Many early trials showed no treatment effects. Because of the recent publication of new information, a review of available evidence concerning this issue was undertaken. Eight randomized clinical trials were assessed regarding trial design. The studies varied according to generalizability, diagnostic criteria, choice of therapy, outcome measures assessed, evaluation of compliance, methods of analysis, duration of follow-up, determination of side effects, and ability to exclude a type 2 error. While many of the earlier studies found no treatment effects, they lacked methodologic rigor; more recent studies demonstrated positive treatment effects. Pooling of results from similar trials supports a notable treatment effect in the prevention of stroke. There is also evidence that the elderly are not more susceptible to side effects of antihypertensive drugs, as is generally believed. The best evidence suggests the hypertensive elderly should be treated.

摘要

15年多来的临床试验探讨了治疗老年高血压患者的治疗效用。许多早期试验未显示出治疗效果。由于最近有新信息发表,因此对有关该问题的现有证据进行了综述。对八项随机临床试验的试验设计进行了评估。这些研究在可推广性、诊断标准、治疗选择、评估的结局指标、依从性评估、分析方法、随访持续时间、副作用的确定以及排除II型错误的能力等方面存在差异。虽然许多早期研究未发现治疗效果,但它们缺乏方法学上的严谨性;最近的研究显示出了积极的治疗效果。对类似试验结果的汇总支持在预防中风方面有显著的治疗效果。也有证据表明,老年人并不像普遍认为的那样更容易受到抗高血压药物副作用的影响。最佳证据表明,老年高血压患者应该接受治疗。

相似文献

1
Should the elderly hypertensive be treated? Evidence from clinical trials.老年高血压患者是否应接受治疗?来自临床试验的证据。
Arch Intern Med. 1987 Nov;147(11):1933-7.
2
[Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].[心血管疾病中的钙拮抗剂。发病率和死亡率试验的临床证据]
Drugs. 2000;59 Spec No 2:25-37.
3
Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).奥美沙坦与钙拮抗剂随机对照(OSCAR)研究的原理、设计及患者基线特征:一项比较日本老年高危高血压患者中高剂量血管紧张素II受体阻滞剂(ARB)单药治疗与ARB联合钙通道阻滞剂治疗心血管事件发生率的研究(ClinicalTrials.gov编号:NCT00134160)
Hypertens Res. 2009 Jul;32(7):575-80. doi: 10.1038/hr.2009.60. Epub 2009 May 15.
4
Stroke in the elderly treated for systolic hypertension (SHEP) part II--mortality.老年收缩期高血压治疗的中风(SHEP)第二部分——死亡率
J Insur Med. 1992 Spring;24(1):28-31.
5
[The intervention trial in the evaluation of antihypertensive therapy].
Ann Ital Med Int. 1995 Oct;10 Suppl:108S-111S.
6
[Retrospective studies and prospects of therapy for hypertension].[高血压治疗的回顾性研究与展望]
Herz. 1995 Dec;20(6):370-89.
7
Hypertension in the elderly.老年人高血压
Basic Res Cardiol. 1998;93 Suppl 2:43-6.
8
Large therapeutic studies in elderly patients with hypertension.
J Hum Hypertens. 2002 Mar;16 Suppl 1:S38-43. doi: 10.1038/sj.jhh.1001340.
9
[Treatment of elderly hypertension with Ca channel blockers].[钙通道阻滞剂治疗老年高血压]
Clin Calcium. 2005 Oct;15(10):1717-25.
10
[Antihypertensive therapy in the elderly: results of large trials].[老年人的抗高血压治疗:大型试验结果]
Ital Heart J Suppl. 2001 Nov;2(11):1161-9.

引用本文的文献

1
Pharmacotherapy for hypertension in adults 60 years or older.60岁及以上成年人高血压的药物治疗
Cochrane Database Syst Rev. 2019 Jun 5;6(6):CD000028. doi: 10.1002/14651858.CD000028.pub3.
2
Steady state pharmacokinetics of hydrolysed bopindolol in young and elderly men.水解波吲洛尔在青年和老年男性中的稳态药代动力学
Eur J Clin Pharmacol. 1991;41(2):175-8. doi: 10.1007/BF00265913.
3
Clinical trials and clinical practice in the elderly. A focus on hypertension.
Drugs Aging. 1992 Mar-Apr;2(2):86-94. doi: 10.2165/00002512-199202020-00002.